Imetelstat News 2019

Geron Announces Expansion of Leadership Team with Appointment of

Geron Announces Expansion of Leadership Team with Appointment of

Hydro-Seq enables contamination-free high-throughput single-cell RNA

Hydro-Seq enables contamination-free high-throughput single-cell RNA

2 Small-Cap Stocks Rising on New

2 Small-Cap Stocks Rising on New "Buy" Ratings

Geron Plunges 68% as J&J Ends Partnership That Had Ignited Stock

Geron Plunges 68% as J&J Ends Partnership That Had Ignited Stock

CRISPR, Intellia, and Caribou Receive a US Genome-Editing Patent

CRISPR, Intellia, and Caribou Receive a US Genome-Editing Patent

GERN Stock Price and Chart — NASDAQ:GERN — TradingView

GERN Stock Price and Chart — NASDAQ:GERN — TradingView

Geron : Provides Imetelstat Program Update | MarketScreener

Geron : Provides Imetelstat Program Update | MarketScreener

Addressing Unmet Needs in Myelofibrosis (Transcript)

Addressing Unmet Needs in Myelofibrosis (Transcript)

Myelofibrosis market will exceed $ 1 billion by 2025, says

Myelofibrosis market will exceed $ 1 billion by 2025, says

The Top Small Cap Biotech Stocks for 2019 | Stock Wire News

The Top Small Cap Biotech Stocks for 2019 | Stock Wire News

Ongoing trials of ruxolitinib, momelotinib and imetelstat in

Ongoing trials of ruxolitinib, momelotinib and imetelstat in

Pharmaceutical Pipeline | Johnson & Johnson

Pharmaceutical Pipeline | Johnson & Johnson

Geron Starts Phase 3 Clinical Trial in Lower Risk Myelodysplastic

Geron Starts Phase 3 Clinical Trial in Lower Risk Myelodysplastic

Geron Starts Phase 3 Clinical Trial in Lower Risk Myelodysplastic

Geron Starts Phase 3 Clinical Trial in Lower Risk Myelodysplastic

Could Geron Corporation Be a Millionaire-Maker Stock? -- The Motley Fool

Could Geron Corporation Be a Millionaire-Maker Stock? -- The Motley Fool

Scientists see inner workings of enzyme telomerase  ecancer - News

Scientists see inner workings of enzyme telomerase ecancer - News

Geron Competitors, Revenue and Employees - Owler Company Profile

Geron Competitors, Revenue and Employees - Owler Company Profile

Laurie Adamson, Author at ASH Clinical News - Page 2 of 50

Laurie Adamson, Author at ASH Clinical News - Page 2 of 50

Geron Corp  (GERN) Stock Message Board - InvestorsHub

Geron Corp (GERN) Stock Message Board - InvestorsHub

The Telomerase Inhibitor Imetelstat Depletes Cancer Stem Cells in

The Telomerase Inhibitor Imetelstat Depletes Cancer Stem Cells in

Imetelstat provides durable transfusion independence in lower risk

Imetelstat provides durable transfusion independence in lower risk

Could activating telomerase trick the ageing process?

Could activating telomerase trick the ageing process?

The Toxicity Of Geron's Imetelstat May Lead To Accelerated FDA

The Toxicity Of Geron's Imetelstat May Lead To Accelerated FDA

Geron Corporation (GERN) Stock | Spikes On Positive Drug Studies

Geron Corporation (GERN) Stock | Spikes On Positive Drug Studies

imetelstat tagged Tweets and Downloader | Twipu

imetelstat tagged Tweets and Downloader | Twipu

Volume 10 38 | Sep 27 - Cord Blood News

Volume 10 38 | Sep 27 - Cord Blood News

Despite responses, imetelstat won't move forward in ET | MDedge

Despite responses, imetelstat won't move forward in ET | MDedge

Emerging translational science discoveries, clonal approaches, and

Emerging translational science discoveries, clonal approaches, and

Geron: A Very Long Wait For A Very Long Shot - Geron Corporation

Geron: A Very Long Wait For A Very Long Shot - Geron Corporation

J&J lines up 10 blockbusters and signs Achillion and Novo Nordisk

J&J lines up 10 blockbusters and signs Achillion and Novo Nordisk

Bioconjugated Oligonucleotides: Recent Developments and Therapeutic

Bioconjugated Oligonucleotides: Recent Developments and Therapeutic

IMbark tagged Tweets and Download Twitter MP4 Videos | Twitur

IMbark tagged Tweets and Download Twitter MP4 Videos | Twitur

Frontiers | DeCoST: A New Approach in Drug Repurposing From Control

Frontiers | DeCoST: A New Approach in Drug Repurposing From Control

23rd Congress of EHA Final Program by Loyals - issuu

23rd Congress of EHA Final Program by Loyals - issuu

Geron Corp  (GERN) Stock Message Board - InvestorsHub

Geron Corp (GERN) Stock Message Board - InvestorsHub

Geron Q2 Loss Narrower-than-Expected, Imetelstat in Focus - Analyst

Geron Q2 Loss Narrower-than-Expected, Imetelstat in Focus - Analyst

Geron's Stock Plunges as J&J Ends Imetelstat Collaboration

Geron's Stock Plunges as J&J Ends Imetelstat Collaboration

Pharmaceuticals – Three therapies to support growth | StocksBNB

Pharmaceuticals – Three therapies to support growth | StocksBNB

Geron Corp (NASDAQ:GERN) Stock Sentiment Increases | Invest Tribune

Geron Corp (NASDAQ:GERN) Stock Sentiment Increases | Invest Tribune

Transient Telomerase Inhibition with Imetelstat Impacts DNA Damage

Transient Telomerase Inhibition with Imetelstat Impacts DNA Damage

Frontiers | DeCoST: A New Approach in Drug Repurposing From Control

Frontiers | DeCoST: A New Approach in Drug Repurposing From Control

Telomerase Inhibitor Imetelstat Reverses Marrow Fibrosis

Telomerase Inhibitor Imetelstat Reverses Marrow Fibrosis

Geron's Stock Plunges as J&J Ends Imetelstat Collaboration - Nasdaq com

Geron's Stock Plunges as J&J Ends Imetelstat Collaboration - Nasdaq com

Geron in up to $935 million deal with Janssen for imetelstat

Geron in up to $935 million deal with Janssen for imetelstat

Addressing Unmet Needs in Myelofibrosis (Transcript)

Addressing Unmet Needs in Myelofibrosis (Transcript)

Ron Reblando - @RonReblando Twitter Profile and Downloader | Twipu

Ron Reblando - @RonReblando Twitter Profile and Downloader | Twipu

GERN Stock Price and Chart — NASDAQ:GERN — TradingView

GERN Stock Price and Chart — NASDAQ:GERN — TradingView

Geron Announces Two Presentations on Imetelstat at Upcoming European

Geron Announces Two Presentations on Imetelstat at Upcoming European

Telomerase-Based Therapies Emerging Slowly | JNCI: Journal of the

Telomerase-Based Therapies Emerging Slowly | JNCI: Journal of the

A Look At Johnson & Johnson's Late-Stage Pharmaceuticals Pipeline

A Look At Johnson & Johnson's Late-Stage Pharmaceuticals Pipeline

Ayalew Tefferi MD on Imetelstat as Therapy for Myelofibrosis - The

Ayalew Tefferi MD on Imetelstat as Therapy for Myelofibrosis - The

Geron's Stock Plunges as J&J Ends Imetelstat Collaboration

Geron's Stock Plunges as J&J Ends Imetelstat Collaboration

Ayalew Tefferi MD on Imetelstat as Therapy for Myelofibrosis - The

Ayalew Tefferi MD on Imetelstat as Therapy for Myelofibrosis - The

Xconomy: Sierra Oncology Acquires Gilead's Stalled Myelofibrosis Drug

Xconomy: Sierra Oncology Acquires Gilead's Stalled Myelofibrosis Drug

PV Reporter - MPN Patient Resource Hub

PV Reporter - MPN Patient Resource Hub

3 Reasons This Clinical-Stage Biotech Is an Incredible Bargain

3 Reasons This Clinical-Stage Biotech Is an Incredible Bargain

Beyond JAK2 Inhibitors: A Systematic Review of Management Strategies

Beyond JAK2 Inhibitors: A Systematic Review of Management Strategies

Geron Starts Phase 3 Clinical Trial in Lower Risk Myelodysplastic

Geron Starts Phase 3 Clinical Trial in Lower Risk Myelodysplastic

Role for Telomerase in Pulmonary Hypertension | Circulation

Role for Telomerase in Pulmonary Hypertension | Circulation

Ayalew Tefferi MD on Imetelstat as Therapy for Myelofibrosis - The

Ayalew Tefferi MD on Imetelstat as Therapy for Myelofibrosis - The

GERN - Geron Corporation | Crowdsourced Stock Ratings

GERN - Geron Corporation | Crowdsourced Stock Ratings

Evaluating Imetelstat for Patients With Relapsed/Refractory

Evaluating Imetelstat for Patients With Relapsed/Refractory

Beyond JAK2 Inhibitors: A Systematic Review of Management Strategies

Beyond JAK2 Inhibitors: A Systematic Review of Management Strategies

IMbark tagged Tweets and Download Twitter MP4 Videos | Twitur

IMbark tagged Tweets and Download Twitter MP4 Videos | Twitur

The Telomerase Antagonist, Imetelstat, Efficiently Targets

The Telomerase Antagonist, Imetelstat, Efficiently Targets

Geron Stock Up More Than 50% in 2019 So Far: Here's Why

Geron Stock Up More Than 50% in 2019 So Far: Here's Why

A method for measuring the distribution of the shortest telomeres in

A method for measuring the distribution of the shortest telomeres in

GERN | Geron Stock Price - Investing com

GERN | Geron Stock Price - Investing com

Could Geron Be a Millionaire-Maker Stock? -- The Motley Fool

Could Geron Be a Millionaire-Maker Stock? -- The Motley Fool

Current landscape and future directions for lower-risk MDS treatment

Current landscape and future directions for lower-risk MDS treatment

Geron: Science And Silence - Geron Corporation (NASDAQ:GERN

Geron: Science And Silence - Geron Corporation (NASDAQ:GERN

Amsterdam, June 13-16, 2019 - Oncoletter, Webportal für Onkologie

Amsterdam, June 13-16, 2019 - Oncoletter, Webportal für Onkologie

Geron's (GERN) Q1 Earnings Beat, Revenues Miss, Stock Up - Nasdaq com

Geron's (GERN) Q1 Earnings Beat, Revenues Miss, Stock Up - Nasdaq com

Why Knight Transportation, Geron, and Rent-A-Center Jumped Today

Why Knight Transportation, Geron, and Rent-A-Center Jumped Today

Current landscape and future directions for lower-risk MDS treatment

Current landscape and future directions for lower-risk MDS treatment

Did Geron's Big Announcement Just Go Unnoticed? -- The Motley Fool

Did Geron's Big Announcement Just Go Unnoticed? -- The Motley Fool

SURVEY AND SUMMARY Chemistry, mechanism and clinical status of

SURVEY AND SUMMARY Chemistry, mechanism and clinical status of

Could Geron Corporation Be a Millionaire-Maker Stock? -- The Motley Fool

Could Geron Corporation Be a Millionaire-Maker Stock? -- The Motley Fool

Institutional Investors Are Buying Geron Corp (NASDAQ:GERN) | Mak Daily

Institutional Investors Are Buying Geron Corp (NASDAQ:GERN) | Mak Daily

Geron Corp  (GERN) Stock Message Board - InvestorsHub

Geron Corp (GERN) Stock Message Board - InvestorsHub

Pharmaceutical Pipeline | Johnson & Johnson

Pharmaceutical Pipeline | Johnson & Johnson

Geron Corp (GERN) Commences Phase 3 Clinical Trial in Lower Risk

Geron Corp (GERN) Commences Phase 3 Clinical Trial in Lower Risk

Geron Corporation (GERN) Stock Price, Quote, History & News

Geron Corporation (GERN) Stock Price, Quote, History & News

Xconomy: Bio Roundup: Amarin's Stunner, Lung Cancer News, Data Dumps

Xconomy: Bio Roundup: Amarin's Stunner, Lung Cancer News, Data Dumps